Partner Brian Burke (New York/Shanghai – Litigation) presented on the topic of “Curing Corruption in China’s Healthcare Industry – Risks and Opportunities” at a briefing hosted by The British Chamber of Commerce in Hong Kong. The briefing addressed the following topics:

• Key FCPA/UKBA enforcement risks in China’s healthcare industry
• Case Studies: Lessons from notable enforcement cases (including GSK, Novartis, Astra Zeneca, SciClone and BMS)
• Observations on the latest kinds of employee and third-party misconduct
• How to promote compliance and mitigate enforcement risks